For decades, the idea of a drug that could rewind aspects of human aging has belonged more to science fiction than hospital formularies. That boundary is starting to blur as a gene therapy called ...

The race to slow, halt, or even reverse aging has moved from science fiction into the regulatory record. A Harvard-linked ...

Epigenomics is at the forefront of biomedical innovation, offering unprecedented insights into the mechanisms that regulate ...

In the field of cancer research, understanding the intricate complexity of tumor biology remains a challenge. Cancer is driven by numerous molecular and ...

The COVID-19 pandemic gave us tremendous perspective on how wildly symptoms and outcomes can vary between patients ...